WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...

The global alopecia treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach from USD 3.62 billion in 2025 to USD 5.20 billion by 2033, growing at a CAGR of 4.1% during ...

Samantha Busch’s Heartfelt Revelation on Beating Hair Loss shares her emotional battle with alopecia, resilience through ...

I can tell you that VDPHL01 has a unique profile unlike current FDA-approved treatments, which are associated with cardiac ...

Q32 Bio (Nasdaq: QTTB) has announced a corporate restructuring, shifting its focus entirely to the development of its lead ...

In modern medicine, alopecia treatment is essential since It reduces hair loss and encourages growth. Minoxidil, finasteride, corticosteroids, 5-alpha reductase inhibitors, and cyclosporine can ...

Injectable botulinum toxin was associated with significant efficacy and sufficient safety outcomes in treating patients with androgenetic alopecia.

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

If you haven’t found the right treatment for your alopecia areata yet, it may be right around the corner. There’s no cure for alopecia areata, but even with this condition, your hair follicles ...

The chronicity of alopecia areata is linked to persistent immune dysregulation and genetic predisposition. Panelists discuss how the decision to treat vs observe alopecia areata (AA) depends on ...

Alopecia areata affects nearly 1 in 1,000 people ... the psychological health and quality of life of patients. Current treatments focus on symptom management rather than providing a consistent ...